Nutritional management of cancer patients;Prise en charge nutritionnelle du patient cancereux

Hepato-Gastro

Volumn 5, Issue 6, 1998, Pages 415-422

  Reimund, Jean Marie ^a   Duclos, Bernard ^a   Scheer, Olivier ^a   Dron, Karine ^a   Baumann, René ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CANNABINOID; CORTICOSTEROID; CYPROHEPTADINE; CYTOKINE; CYTOKINE ANTIBODY; GAMMA INTERFERON; GLUTAMINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MEGESTROL ACETATE; MONOCLONAL ANTIBODY; NUCLEOTIDE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

CANCER PATIENT; DIGESTIVE SYSTEM CANCER; ENTERIC FEEDING; GLUCOSE METABOLISM; HUMAN; LIPID METABOLISM; MULTIMODALITY CANCER THERAPY; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PROTEIN METABOLISM; SHORT SURVEY;

EID: 0031647046     PISSN: 12537020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (82)

1. Warren S. The immediate cause of death in cancer. Am J Med Sci 1932; 184: 610-5.
2. DeWis WD, Begg C, Lavin PT, Bennet JM, Bertino JR, Cohen MH, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980; 69: 491-7.
3. Pisters PWT, Pearlstone DB Protein and amino acid metabolism in cancer cachexia: investigative techniques and therapeutic interventions. Crit Rev Clin Lab Sci 1993; 30: 223-72.
4. Lawson DH, Richmond A, Nixon DW, Rudman D. Metabolic approaches to cancer cachexia. Annu Rev Nutr 1982; 2: 277-301.
5. Norton JA, Peacock JL, Morrison SD. Cancer cachexia. CRC Crit Rev Oncol Hematol 1987; 7: 289-327.
6. Detsky AS, Baker JP, O'Rourke K, Goel V. Perioperative parenteral nutrition: a meta-analysis. Ann Intern Med 1987; 107: 195-203.
7. Nixon DW, Heymsfield SB, Cohen AE, Kutner MH, Ansley J, Lawson DH, et al. Protein-calorie undernutrition in hospitalized cancer patients. Am J Med 1980, 68: 683-90.
8. Bachmann P, Gordani B, Ranchere JY, Lallemand Y, Combret D, Latour JF, et al. Evaluation de l'indication et de la qualité de la prise en charge nutritionnelle en cancérologie médicale Nutr Clin Métabol 1998; 12: 3-11.
9. Belghiti J, Longonnet F, Bourstyn E, Fekete F. Surgical implications of malnutrition and immunodeficiency in patients with carcinoma of the oesophagus. Br J Surg 1983; 70: 339-41.
10. Fein R, Kelsen DP, Geller N, Bains M, McCormark P, Brennan MF, et al. Adenocarcinoma of the esophagus and gastroesophageal junction: prognostic factors and results of therapy. Cancer 1985; 56: 2512-8.
11. Gail MH, Eagan RT, Feld R, Ginsberg, Goodell B, Hill L, et al. Prognostic factors in patients with resected stage 1 non-small-cell lung cancer: a report from the lung cancer study group. Cancer 1984; 54: 1802-3.
12. McWhirter JP, Pennington CR. Incidence and recognition of malnutrition in hospital. Br Med J 1994; 308: 945-8.
13. Edington J, Kon P, Martyn CN. Prevalence of malnutrition in patients in general practice. Clin Nutr 1996; 15: 60-3.
14. Tisdale MJ. Cancer cachexia: metabolic alterations and clinical manifestations. Nutrition 1997; 13: 1-7.
15. Bozzetti F, Agradi E, Ravera E. Anorexia in cancer patients: prevalence and impact on nutritional status. Clin Nutr 1989; 8 35-43
16. Rossi Fanelli F, Cangiano C. Increased availability of tryptophan in brain as a common pathogenic mechanism for anorexia associated with different diseases Nutrition 1991; 7: 364-7.
17. Weingarten HP. Cytokines and food intake: the relevance of the immune system to the student of ingestive behavior. Neurosci Biobehav Rev 1996; 20: 163-70
18. Mann WJ Surgical management of radiation enteropathy. Surg Clin North Am 1991; 71: 977-90.
19. Cori CF, Cori GT. The carbohydrate metabolism of tumors. II Changes in sugar, lactic acid, and CO2-combining power of blood passing through a tumor. J Biol Chem 1925; 66: 397-405.
20. Gullino PM, Grantham FH, Courtney AH. Glucose consumption by transplanted tumors in vivo. Cancer Res 1967; 27: 1031-40.
21. Eden E, Edstrom S, Bennegard K, Schersten T, Lundholm K. Glucose flux in relation to energy expenditure in malnourished patients with and without cancer during periods of fasting and feeding. Cancer Res 1984, 44: 1718-23.
22. Lundholm K, Edstrom S, Karlberg I, Schersten T. Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients. Cancer 1982; 50 1142-50.
23. Waterhouse C, Jeanpretre N, Keilson J. Gluconeogenesis from alanine in patients with progressive malignant disease. Cancer Res 1979, 39: 1968-72.
24. Shaw JH, Wolfe RR. Glucose and urea kinetics in patients with early and advanced gastrointestinal cancer: the response to glucose infusion, parenteral feeding, and surgical resection. Surgery 1987; 101: 181-91.
25. Chlebowski RT, Heber D, Richardson B, Block JB. Influence of hydrazine sulfate on abnormal carbohydrate metabolism in cancer patients with weight loss. Cancer Res 1984; 44: 857-61.
26. Lundholm K, Holm G, Scherste T Insulin resistance in patients with cancer. Cancer Res 1978; 38: 4665-70.
27. McCall JL, Tuckey JA, Parry BR Serum tumor necrosis factor alpha and insulin resistance in gastrointestinal cancer. Br J Surg 1992; 79: 1361-3.
28. Fredrix EW, Soeters PB, Wouters EF, Deerenberg IM, von Meyenfeld MF, Saris WH. Effect of different tumor types on resting energy expenditure. Cancer Res 1991; 51: 6138-41.
29. Jeevanandam M, Horowitz GD, Lowry SF, Brennan MF. Cancer cachexia and the rate of whole body lipolysis in man Metabolism 1986; 35: 304-10
30. Vlassara H, Spiegel RJ, San Doval D, Cerami A Reduced plasma lipoprotein lipase activity in patients with malignancy-associated weight loss. Horm Metab Res 1986; 10: 698-703.
31. Devereux DF, Redgrave TG, Tilton M, Hollander D, Deckers PJ Intolerance to administered lipids in tumor-bearing animals. Surgery 1984; 96: 414-9.
32. Douglas RG, Shaw JH. Metabolic effects of cancer. Br J Surg 1990; 77 246-54.
33. Fearon KCH, Hansell DT, Preston T, Plumb JA, Davies J, Shapiro D, et al. Influence of whole body protein turnover rate on resting energy expenditure in patients with cancer Cancer Res 1988; 48, 2590-5.
34. Jeevanandam M, Lowry SF, Horowitz GD, Brennan MF. Cancer cachexia and protein metabolism. Lancet 1984; 2: 1423-6.
35. Smith KL, Tisdale MJ. Mechanism of muscle protein degradation in cancer cachexia. Br J Cancer 1993; 68: 314-8.
36. de Blaauw I, Deute NE, Boers W, von Meyenfeld MF. Hepatic amino acid and protein metabolism in non-anorectic, moderately cachectic tumor-bearing rats. J Hepatol 1997; 26: 396-408.
37. Fearon KCH, McMillan DC, Preston T, Winstanley P, Cruickshank A, Shenkin A Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg 1991, 213-26-31.
38. Tayek JA, Blackburn GA, Bistrian GA. Alterations in whole body, muscle, liver and tumor tissue protein synthesis and degradation in Novikoff hepatoma and Yoshida sarcoma tumor growth studied in vivo. Cancer Res 1988; 1454-8.
39. Garcia Martinez C, Lopez Soriano FJ, Argiles JM Alanine metabolism in rats bearing the Yoshida AH-130 ascites hepatoma Cancer Lett 1994; 87: 123-30.
40. de Blaauw I, Van der Hulst RRWJ, Deutz NEP, von Meyenfeldt MF. Glutamine depletion and increased gut permeability in non anorectic, non weight losing tumor bearing rats. Gastroenterology 1997, 112 118-26.
41. Fahr MJ, Kornbluth J, Blossom S, Schaeffer R, Klimberg VS, Harry M Glutamine enhances immunoregulation of tumor growth. J Parent Enter Nutr 1994; 18: 471-6.
42. Tremel H, Kienle B, Weileman LS, Stehle P, Furst P. Glutamine dipeptide-supplemented parenteral nutrition maintains intestinal function in critical ill. Gastroenterology 1994, 107: 1595-601
43. Espat NJ, Moldawer LL, Copeland EM. Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients. J Surg Oncol 1995; 58: S77-82
44. Noguchi Y, Yoshikawa T, Matsumoto A, Svaninger G, Gelin J. Are cytokines possible mediators of cancer cachexia? Surg Today 1996, 26: 467-75.
45. Laviano A, RenvyleT, Yang ZJ. From laboratory to bedside: new strategies in the treatment of malnutrition in cancer patients. Nutrition 1996, 12: 112-22.
46. Roubenoff R. Inflammatory and hormonal mediators of cachexia. J Nutr 1997; 127: 1014S-16S.
47. McFie J, Burkinshaw L, Oxby C, Holmfield JHM, Hill GL. The effect of gastrointestinal malignancy on resting metabolic expenditure. Br J Surg 1982; 69: 443-6
48. Knox LS, Crosby LO, Feurer ID, Buzby GP, Miller CL, Mullen JL. Energy expenditure in malnourished cancer patients. Ann Surg 1983; 197: 152-62.
49. Hyltander A, Drott C, Körner U, Sandström R, Lundholm K. Elevated energy expenditure in cancer patients with solid tumors. Eur J Cancer 1991, 27 9-12.
50. Costa G Cachexia, the metabolic component of neoplastic diseases. Cancer Res 1977; 37: 2327-35.
51. Heymsfield SB, McManus GB Tissue components of weight loss in cancer patients. Cancer 1985; 55: 238-49
52. Lerebours E, Dechelotte P, Michel P Prévalence et évaluation de la dénutrition chez le cancéreux. Nutr Clin Méfaboi 1997; 11: S373-6.
53. Buzby GP, Knox LS, Crosby LO, Eisenberg JM, Haakenson JM, Mac Neal GE, et al. Study protocol: a randomized clinical trial of total parenteral nutrition in malnourished surgical patients. Am J Clin Nutr 1988; 47(suppl): 366-81.
54. Detsky AS, McLaughlin JR, Baker JP, Abrams HB, L'Abbe KA, Whitwell J, et al. What is subjective global assessment of nutritional status. J Parenter Enter Nutr 1987; 11: 8-13.
55. Ottery FD. Supportive nutrition to prevent cachexia and improve quality of life. Sem Oncol 1995; 22 (suppl 3): 98-111
56. Cozzaglio L, Bozzeti F. Does parenteral nutrition increase tumor growth? A review Tumori 1994, 80: 169-74.
57. Gouttebel MC. Nutrition artificielle et croissance tumorale. Nutr Clin Métabol 1997; 11 (suppl 4): 377-82.
58. Scrimshaw NS, SanGiovanni JP. Synergism of nutrition, infection, and immunity Am J Clin Nutr 1997, 66 (suppl): 464-77.
59. Naber THJ, Schermer T, de Bree A, Nusteling K, Eggink L, Kruimel JW, et al. Prevalence of malnutrition in nonsurgical hospitalized patients and its association with disease complications. Am J Clin Nutr 1997; 66: 1232-9.
60. Di Costanzo J. Influence de l'état nutritionnel préopératoire sur la morbidité postopératoire. Ann Fr Anesth Réanim 1995; 14 (suppl 2): 33-8.
61. Hickman DM, Miller RA, Rombeau JL, Twombey PL, Frey CF. Serum albumin and body weight as predictors of postoperative course in colorectal cancer. J Parenter Enter Nutr 1980;4: 314-6.
62. Meguid MM, Meguid V. Preoperative identification of the surgical cancer patient in need of postoperative supportive total parenteral nutrition. Cancer 1985; 55: 258-62.
63. Braga M, Gianotti L, Radaelli G, Cristallo M, Baccari P, Danlin S, et al. Evaluation of the predictive performance of nutritional indicators by receiver-operating characteristic curve analysis. J Parenter Enter Nutr 1991, 15: 619-24.
64. Von Meyenfeldt MF, Meijerink JHJ, Rouflart MMJ, Builmaassen MTHJ, Soeters PB. Perioperative nutritional support: a randomized clinical trial. Clin Nutr 1992; 11: 180-6.
65. Nutrition artificielle péri-opératoire en chirurgie programmée de l'adulte: recommandations de la conférence de consensus. Nutr Clin Métabol 1995; 9: 233-42.
66. Klein S, Kinney JM, Alpers D, Hellerstein M, Murray M, Twomey P, et al. Nutrition support in clinical practice: review of published data and recommandations for future research directions. J Parenter Enter Nufr 1997, 21: 133-56.
67. Ottery FD. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 1996, 12 (suppl 1): S15-9.
68. Hays DM, Merritt RJ, White L, Ashley J, Siegel SE Effect of total parenteral nutrition on marrow recovery during induction therapy for acute non-lymphocytic leukemia in childhood Med Pediatr Oncol 1983, 11: 134-40.
69. Szeluga DJ, Stuart RK, Brookmeyer R, Utermohlen V, Santos GW. Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res 1987, 47 3309-16
70. Weisdorf SA, Lysne J, Wind D, Haake RJ, Sharp HL, Goldman A, et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation 1987, 43: 833-8.
71. Ribaud P, Socié G, Parquet N, Gluckman E. Prise en charge nutritionnelle des malades allogreffés de moelle Nutr Clin Métabol 1997; 11 (suppl 4): 401-4.
72. Klein S, Simes J, Blackburn GL. Total parenteral nutrition and cancer clinical trials. Cancer 1986; 58: 1378-86.
73. McGeer AJ, Detsky AS, O'Rourke K Parenteral nutrition in cancer patients undergoing chemotherapy: a meta-analysis. Nutrition 1990; 6: 233-40.
74. American College of Physicians. Parenteral nutrition in patients receiving cancer chemotherapy. Ann Intern Med 1989; 110: 734-6.
75. Klein S, Koretz RL. Nutrition support in patients with cancer: What do the data really show? Nutr Clin Pract 1994; 9: 91-100.
76. Donaldson SS. Nutritional support as an adjunct to radiation therapy. J Parenter Enter Nutr 1984; 8: 302-9.
77. Grindel C, Whitmer K, Barsevick A. Quality of life and nutritional support in patients with cancer. Cancer practice 1996; 4 81-7.
78. Bozzeti F Home total parenteral nutrition in cancer patients. Clin Nutr 1995; 14 (suppl 1): 36-40.
79. Howard L. Home parenteral and enteral nutrition in cancer patients. Cancer 1993; 72: 3531-41.
80. Van Gossum A, Bakker H, De Francesco A, Ladefoged K, Leon-Sanz M, Messing B, et al. Home parenteral nutrition in adults a multicentre survey in Europe in 1993. Clin Nutr 1996; 15: 53-9.
81. Van Gossum A, Messing B Home parenteral nutrition in adults: new trends raise new questions. Nutrition 1997; 13: 479-80.
82. Déchelotte P. Pharmacological nutrition and immune nutrition in cancer patients. In: Cynober L, Furst P, Lawin P Eds. Pharmacological nutrition - Immune nutrition. Munich . Zuckschwerdt Verlag, 1995: 122-34.